# C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

> **NCT01151735** · PHASE4 · WITHDRAWN · sponsor: **Penn State University**

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** C-1-esterase
- **DRUG:** C-1-esterase
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01151735
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PennState would not allow the study to move forward
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151735, "C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01151735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*